Table: Kyorin Holdings -2017/18 group results

Kyorin Pharmaceutical

10/05/2018 06:30

May 10 (Reuters)- 
          Kyorin Holdings Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2018    Mar 31, 2017   Mar 31, 2019     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          110.64          115.37         114.40        50.20    
               (-4.1 pct)      (-3.4 pct)     (+3.4 pct)    (-1.1 pct) 
  Operating        8.82           10.41           8.60         1.90    
               (-15.3 pct)     (-47.0 pct)    (-2.5 pct)   (+31.6 pct) 
  Recurring        9.35           10.87           9.20         2.20    
               (-14.1 pct)     (-45.6 pct)    (-1.6 pct)   (+29.9 pct) 
  Net
  Net              6.57            7.31           6.60         1.50    
               (-10.0 pct)     (-46.4 pct)    (+0.4 pct)   (+20.9 pct) 
  EPS           89.28 yen       99.45 yen      89.49 yen    20.34 yen  
  Ann Div       58.00 yen       58.00 yen      58.00 yen               
  -Q2 Div       20.00 yen       20.00 yen      20.00 yen               
  -Q4 Div       38.00 yen       38.00 yen      38.00 yen               
  
  NOTE - Kyorin Holdings Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T